USE OF CYCLOSPORINS IN THE TREATMENT OF INFLAMMATORY AUTOIMMUNE DISEASES - Patent 1082130

(19)

(11)

EP 1 082 130 A1

(12)

(43)	Date of publication:
	14.03.2001 Bulletin 2001/11

(21)	Application number: 99926489.8

(22)	Date of filing: 31.05.1999

(51)	International Patent Classification (IPC)⁷: A61K 38/13

(86)	International application number:
	PCT/EP9903/770

(87)	International publication number:
	WO 9962/540 (09.12.1999 Gazette 1999/49)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE
	Designated Extension States:
	SI

(30)

Priority:

02.06.1998 GB 9811854

(71)	Applicants:
	Novartis AG 4058 Basel (CH) BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE CY Novartis-Erfindungen Verwaltungsgesellschaft m.b.H. 1230 Wien (AT) AT

(72)	Inventor:
	HIESTAND, Peter CH-4123 Allschwil (CH)

(74)	Representative: Becker, Konrad et al
	Novartis AG,Corporate Intellectual Property,Patent & Trademark Department 4002 Basel 4002 Basel (CH)

(54)	USE OF CYCLOSPORINS IN THE TREATMENT OF INFLAMMATORY AUTOIMMUNE DISEASES